Cincinnati Business Courier: CCM’s production of ‘Fellow Travelers’ included in list of 2023 arts highlights
Initially workshopped at CCM in 2013, the opera runs March 30-April 2 in Patricia Corbett Theater
The Cincinnati Business Courier recently published Janelle Gelfand’s preview of Cincinnati’s 2023 arts offerings. CCM’s upcoming production of Gregory Spears and Greg Pierce’s Fellow Travelers was included as one of the highlights of the new year.
Described by Gelfand as “one of the most successful new American operas,” the title has strong ties to CCM and Cincinnati. Based on the 2007 novel of the same name by Thomas Mallon, Fellow Travelers was originally workshopped at CCM in 2013 as part of the college’s Opera Fusion: New Works (OF:NW) partnership with Cincinnati Opera.
Cincinnati Opera presented the world premiere of Fellow Travelers in 2016 with a production that was conducted by CCM faculty member Mark Gibson and featured alumnus Joseph Lattanzi (MM Voice, 2015; AD Opera, 2015) singing the role of the opera's co-lead, Hawkins Fuller. The 2016 cast also included alumni Christian Pursell (MM Voice, '17), Paul Scholten (MM Voice, '09), Alexandra Schoeny (DMA Voice, '19) and Talya Lieberman (AD Opera, '16).
Gelfand writes: “Now, a decade after those 2013 workshops, CCM Opera presents Fellow Travelers, March 30-April 2 in Patricia Corbett Theater.” Conducted by CCM alumnus William R. Langley (MM Orchestral Conducting, '18) with co-direction by CCM artist diploma student Daria Zholnerova and CCM faculty member Greg Eldridge, the opera is set at the height of the McCarthy era, when young Timothy Laughlin is eager to join the crusade against Communism. A chance encounter with a handsome, profligate State Department official mamed Hawkins Fuller leads to Laughlin's first job in Washington, D.C., and his first love affair. Drawn into a maelstrom of deceit and intrigue, Laughlin struggles to reconcile his political convictions, his love for God and his love for Fuller — an entanglement that will end in a stunning act of betrayal.
Read the Cincinnati Business Courier’s 2023 arts preview. Tickets for CCM’s upcoming production of Fellow Travelers are on sale now.
Next Lives Here
At the University of Cincinnati, we realize the impact our teaching, research, artistry and service can have on our community and the world. So, we don’t wait for change to happen. We break boundaries, boldly imagine and create what’s Next. To us, today’s possibilities spark tomorrow’s reality. That’s why we are leading urban public universities into a new era of innovation and impact, and that's how we are defining Next for the performing and media arts.
We are UC. Welcome to what's Next.
Featured image at top: Promotional image for CCM's Spring 2023 production of Fellow Travelers. Photo/Mark Lyons
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.